StockpollyBeta
Get App
Popularity #702
ABCL · NASDAQ · Biotechnology

AbCellera Biologics (ABCL)

Discovers antibodies for partners and advances its own clinical candidates.

$12.20
vs last close−0.45 (−3.59%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue791077541794584
Cost of revenue000000000890
Gross profit791077541793704
61756510110078676785665767
Research & development384939414146423955504746
181921232219192225151114
Selling & marketing333333333000
General & administrative141617201916161922000
Other expenses685373713555007
Operating income−55−66−55−93−94−73−63−50−76−29−58−63
16171245312610138984
Interest income11111010109887640
Other non-operating income−3−3−3−3−3−4−4−4−3−9−8−4
Income before tax−39−49−43−48−63−47−53−36−69−19−50−59
Income tax expense−11−1−2−11−12−13−7−2−12−11−6−4
Net income from continuing operations−29−47−41−37−51−34−46−35−57−9−43−55
Net income−29−47−41−37−51−34−46−35−57−9−43−55
EPS, basic−$0.10−$0.16−$0.14−$0.13−$0.17−$0.12−$0.15−$0.12−$0.19−$0.03−$0.14−$0.18
EPS, diluted−$0.10−$0.16−$0.14−$0.13−$0.17−$0.12−$0.15−$0.12−$0.19−$0.03−$0.14−$0.18
Weighted average shares, basic289291293294295295298299299299303306
Weighted average shares, diluted289291293294295295298299299299303306
EBITDA−45−54−45−52−52−55−52−39−66−12−41−42
Depreciation & amortization7973838147778917
EBIT−52−63−52−90−90−69−59−46−74−19−50−59